Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Asset Writedowns and Impairment (2016 - 2026)

Iradimed has reported Asset Writedowns and Impairment over the past 13 years, most recently at $40000.0 for Q1 2026.

  • Quarterly Asset Writedowns and Impairment rose 366.67% to $40000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$29000.0 through Mar 2026, up 59.61% year-over-year, with the annual reading at -$84000.0 for FY2025, 11.58% up from the prior year.
  • Asset Writedowns and Impairment was $40000.0 for Q1 2026 at Iradimed, up from -$875.0 in the prior quarter.
  • Over five years, Asset Writedowns and Impairment peaked at $180788.0 in Q1 2023 and troughed at -$109925.0 in Q3 2024.
  • The 5-year median for Asset Writedowns and Impairment is -$875.0 (2025), against an average of $8541.8.
  • Year-over-year, Asset Writedowns and Impairment surged 4185.09% in 2023 and then plummeted 309.2% in 2024.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $73540.0 in 2022, then crashed by 152.33% to -$38485.0 in 2023, then surged by 90.64% to -$3602.0 in 2024, then surged by 75.71% to -$875.0 in 2025, then skyrocketed by 4671.43% to $40000.0 in 2026.
  • Per Business Quant, the three most recent readings for IRMD's Asset Writedowns and Impairment are $40000.0 (Q1 2026), -$875.0 (Q4 2025), and -$50236.0 (Q3 2025).